Biotech Investors & VC Firms in United States
1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.
Bioscience Equity Partners
DubaiLate Stage
1 person
Heights
Hong KongGrowth–Late Stage
1 person
HSBC Innovation Ventures
LondonSeed–Late Stage
1 person
Manhattan Street Fund
Growth–Late Stage$300M
1 person
Nissay Capital
TokyoPre-Seed–Growth
1 person
Salt Mines Advisors
Pre-Seed–Series A
1 person
Fosun Pharma
Shanghai
JMCR Partners
Hong KongSeed–Late Stage
Stonebridge Ventures
SeoulSeries A–Series C
3 people
IMM Investment
KangnamPre-Seed–Growth
Praxis Spinal Cord Institute
VancouverPre-Seed–Seed
QF Capital
ShenzhenPre-Seed–Series A
RMGP Biopharma Investment Fund
HerzliyaSeed–Series A
6 people
Dauntless VC
Seed
Fubon Financial Holdings
TaipeiSeries A–Series B
Oceanpine Capital
BeijingSeries A–Late Stage
5 people
Esperante Ventures
LondonSeed–Series A$540K – $5.4M
1 person
Morningside Group
Hong KongSeed–Growth
1 person
Hong Kong Science and Technology Parks – incubation programs
Hong KongPre-Seed–Growth
4 people
Oriza Holdings
SuzhouSeed–Series C
2 people
Company K Partners
SeoulSeries A–Series B
CIBC
TorontoPre-Seed–Late Stage
1 person
Treefrog Accelerator
NewmarketSeed–Growth
3 people
Novatio Ventures Inc.
TorontoSeed–Series A
3 people
Related lists
Investors & VC Firms in North America (13326)Investors & VC Firms in United States (12318)Investors & VC Firms in Europe (6083)AI & Machine Learning Investors & VC Firms (5352)Investors & VC Firms in Global (5318)Fintech Investors & VC Firms (5140)Healthtech Investors & VC Firms (4657)SaaS Investors & VC Firms (4528)Enterprise Software Investors & VC Firms (4424)Crypto & Web3 Investors & VC Firms (4140)
Data sourced from public filings and firms' own websites — see our methodology.










